Afficher la couverture 'BORA-dependent PLK1 regulation: A new weapon for cancer therapy? | Cirillo, Luca' en grand format
/5

0 avis

BORA-dependent PLK1 regulation: A new weapon for cancer therapy?

Archive ouverte

Cirillo, Luca | Thomas, Yann | Pintard, Lionel | Gotta, Monica

Edité par CCSD ; Taylor et Francis -

International audience. The mitotic kinase polo like kinase 1 (PLK1) is overexpressed in many cancers and its inhibition slows down proliferation and increases apoptosis in cancer cell lines. Understanding how PLK1 is activated is therefore crucial for the development of novel PLK1 inhibitors with anticancer properties. We recently identified a conserved regulatory loop leading to PLK1 activation that involves cyclin-dependent kinase 1 (CDK1).

Consulter en ligne

Suggestions

Du même auteur

Cdk1 Phosphorylates SPAT-1/Bora to Promote Plk1 Activation in C. elegans and Human Cells.

Archive ouverte | Thomas, Yann | CCSD

International audience. The conserved Bora protein is a Plk1 activator, essential for checkpoint recovery after DNA damage in human cells. Here, we show that Bora interacts with Cyclin B and is phosphorylated by Cyc...

UBAP2L ensures homeostasis of nuclear pore complexes at the intact nuclear envelope

Archive ouverte | Liao, Yongrong | CCSD

International audience. Assembly of macromolecular complexes at correct cellular sites is crucial for cell function. Nuclear pore complexes (NPCs) are large cylindrical assemblies with eightfold rotational symmetry,...

Cdk1 phosphorylates SPAT-1/Bora to trigger PLK-1 activation and drive mitotic entry in C. elegans embryos.

Archive ouverte | Tavernier, Nicolas | CCSD

International audience. The molecular mechanisms governing mitotic entry during animal development are incompletely understood. Here, we show that the mitotic kinase CDK-1 phosphorylates Suppressor of Par-Two 1 (SPA...

Chargement des enrichissements...